Centaurus Financial, Inc. Moderna, Inc. Transaction History

Centaurus Financial, Inc.

$1.44 Billion
Q3 2024

A detailed history of Centaurus Financial, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Centaurus Financial, Inc. holds 6,300 shares of MRNA stock, worth $253,701. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,300

Previous 6,335 0.55%

Holding current value

$253,701

Previous $752,000 44.02%

% of portfolio

0.03%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$63.64 - $125.14 $2,227 - $4,379	-35 Reduced 0.55%	6,300 $421,000
Q2 2024 Sep 20, 2024	SELL	$101.21 - $166.61 $61,535 - $101,298	-608 Reduced 8.76%	6,335 $752,000
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $11,951 - $16,161	-140 Reduced 1.98%	6,943 $739,000
Q4 2023 Feb 26, 2024	BUY	$69.51 - $104.43 $14,875 - $22,348	214 Added 3.12%	7,083 $704,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $6,555 - $8,609	-68 Reduced 0.98%	6,869 $709,000
Q2 2023 Aug 15, 2023	SELL	$118.5 - $160.53 $184,267 - $249,624	-1,555 Reduced 18.31%	6,937 $842,000
Q1 2023 May 17, 2023	BUY	$135.66 - $197.02 $4,748 - $6,895	35 Added 0.41%	8,492 $1.3 Million
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $47,707 - $84,646	-403 Reduced 4.55%	8,457 $1.52 Million
Q3 2022 Dec 05, 2022	SELL	$118.07 - $194.18 $12,987 - $21,359	-110 Reduced 1.23%	8,860 $1.05 Million
Q2 2022 Aug 02, 2022	SELL	$117.13 - $176.59 $43,806 - $66,044	-374 Reduced 4.0%	8,970 $1.28 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $4,931 - $9,166	39 Added 0.42%	9,344 $1.61 Million
Q4 2021 Feb 01, 2022	SELL	$225.82 - $368.51 $136,846 - $223,317	-606 Reduced 6.11%	9,305 $2.36 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $764,445 - $1.67 Million	-3,445 Reduced 25.79%	9,911 $3.81 Million
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $898,717 - $1.63 Million	6,918 Added 107.46%	13,356 $3.14 Million
Q1 2021 Apr 30, 2021	BUY	$109.18 - $185.98 $130,797 - $222,804	1,198 Added 22.86%	6,438 $843,000
Q4 2020 Jan 25, 2021	SELL	$65.74 - $169.86 $257,898 - $666,360	-3,923 Reduced 42.81%	5,240 $547,000
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $29,180 - $50,934	537 Added 6.23%	9,163 $648,000
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $152,088 - $410,080	5,126 Added 146.46%	8,626 $554,000
Q1 2020 Apr 21, 2020	BUY	$17.78 - $31.58 $62,230 - $110,530	3,500 New	3,500 $105,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Account

Centaurus Financial, Inc. Moderna, Inc. Transaction History